Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 172,700 | 289,600 | 251,100 | 227,900 | 206,600 |
| Marketable Securities | N/A | 2,700 | 3,900 | 2,000 | N/A |
| Receivables | 1,124,900 | 1,146,900 | 1,174,300 | 1,136,400 | 1,195,400 |
| Inventories | 677,000 | 725,400 | 711,200 | 700,700 | 686,600 |
| Other current assets | 228,800 | 240,100 | 251,000 | 279,300 | 258,600 |
| TOTAL | $2,203,400 | $2,404,700 | $2,391,500 | $2,346,300 | $2,347,200 |
| Non-Current Assets | |||||
| PPE Net | 2,513,500 | 2,453,600 | 2,455,800 | 2,452,200 | 2,528,300 |
| Intangibles | 1,904,000 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 363,900 | 2,264,500 | 2,297,900 | 2,298,100 | 2,376,800 |
| TOTAL | $4,781,400 | $4,718,100 | $4,753,700 | $4,750,300 | $4,905,100 |
| Total Assets | $6,984,800 | $7,122,800 | $7,145,200 | $7,096,600 | $7,252,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 325,500 | 358,300 | 351,100 | 463,500 | 320,200 |
| Accounts payable and accrued liabilities | 678,100 | 665,900 | 699,000 | 669,400 | 738,900 |
| TOTAL | $2,123,500 | $2,155,900 | $2,080,600 | $2,370,800 | $2,244,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,812,000 | 3,083,300 | 2,958,200 | 2,530,400 | 2,536,900 |
| Other Non-Current Liabilities | 722,300 | 634,300 | 630,400 | 629,800 | 555,900 |
| TOTAL | $4,014,900 | $4,158,600 | $3,989,500 | $3,582,500 | $3,540,100 |
| Total Liabilities | $6,138,400 | $6,314,500 | $6,070,100 | $5,953,300 | $5,784,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,097,948 | 1,103,430 | 1,109,977 | 1,122,110 | N/A |
| Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 5,643,600 | 5,457,300 | 5,261,700 | 4,982,900 | 4,893,700 |
| Other shareholders' equity | -1,836,100 | -1,806,900 | -1,688,100 | -1,681,200 | -1,614,500 |
| TOTAL | $846,400 | $808,300 | $1,075,100 | $1,143,300 | $1,468,100 |
| Total Liabilities And Equity | $6,984,800 | $7,122,800 | $7,145,200 | $7,096,600 | $7,252,300 |